TOSI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.887
AS - Asia 1.584
EU - Europa 1.109
SA - Sud America 244
AF - Africa 217
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 9
Totale 5.066
Nazione #
US - Stati Uniti d'America 1.761
IT - Italia 575
SG - Singapore 485
CN - Cina 320
VN - Vietnam 238
BR - Brasile 173
HK - Hong Kong 145
DE - Germania 69
FR - Francia 62
BD - Bangladesh 59
FI - Finlandia 58
NL - Olanda 55
GB - Regno Unito 47
IN - India 33
PL - Polonia 31
JP - Giappone 28
CA - Canada 27
RU - Federazione Russa 25
TR - Turchia 23
MY - Malesia 22
KR - Corea 19
UA - Ucraina 18
AT - Austria 17
AR - Argentina 16
ID - Indonesia 16
MX - Messico 16
IQ - Iraq 15
PK - Pakistan 15
AE - Emirati Arabi Uniti 14
PH - Filippine 14
SA - Arabia Saudita 14
BJ - Benin 13
SE - Svezia 13
UZ - Uzbekistan 13
ZA - Sudafrica 12
DZ - Algeria 11
MA - Marocco 11
ZM - Zambia 11
CH - Svizzera 10
NP - Nepal 10
AZ - Azerbaigian 9
CO - Colombia 9
NI - Nicaragua 9
VE - Venezuela 9
BS - Bahamas 8
CI - Costa d'Avorio 8
CZ - Repubblica Ceca 8
KG - Kirghizistan 8
MR - Mauritania 8
PE - Perù 8
PT - Portogallo 8
RO - Romania 8
RS - Serbia 8
SK - Slovacchia (Repubblica Slovacca) 8
SO - Somalia 8
AL - Albania 7
ES - Italia 7
GE - Georgia 7
GH - Ghana 7
IL - Israele 7
IR - Iran 7
JO - Giordania 7
KE - Kenya 7
LY - Libia 7
PA - Panama 7
SN - Senegal 7
XK - ???statistics.table.value.countryCode.XK??? 7
BA - Bosnia-Erzegovina 6
CM - Camerun 6
EC - Ecuador 6
EE - Estonia 6
ET - Etiopia 6
GF - Guiana Francese 6
HN - Honduras 6
JM - Giamaica 6
KH - Cambogia 6
MU - Mauritius 6
PY - Paraguay 6
TH - Thailandia 6
UY - Uruguay 6
ZW - Zimbabwe 6
BF - Burkina Faso 5
CR - Costa Rica 5
CV - Capo Verde 5
GM - Gambi 5
GP - Guadalupe 5
GT - Guatemala 5
IE - Irlanda 5
KZ - Kazakistan 5
LB - Libano 5
LU - Lussemburgo 5
MK - Macedonia 5
ML - Mali 5
RE - Reunion 5
SY - Repubblica araba siriana 5
TJ - Tagikistan 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
VC - Saint Vincent e Grenadine 5
AM - Armenia 4
Totale 4.900
Città #
Ashburn 336
Singapore 308
San Jose 294
Fairfield 133
Hong Kong 133
Chandler 86
Ho Chi Minh City 81
Beijing 62
Milan 59
Padova 59
Ann Arbor 52
Houston 49
Rome 49
Los Angeles 48
Hanoi 47
Cambridge 42
Woodbridge 42
Council Bluffs 38
Seattle 37
New York 34
Santa Clara 34
Wilmington 31
Munich 28
Boardman 25
Helsinki 23
Hefei 22
Da Nang 21
Lauterbourg 20
São Paulo 20
Turku 20
Catania 19
Tokyo 18
Dong Ket 17
Orem 17
San Diego 17
Bytom 15
Padua 15
Des Moines 14
Montreal 14
Seoul 14
Cotonou 13
Buffalo 12
Haiphong 12
Naples 12
Nuremberg 12
Chicago 11
Lusaka 11
Tashkent 11
Bolzano 10
Kuala Lumpur 10
Selvazzano Dentro 10
Venice 10
Baku 9
Cagliari 9
Manchester 9
Shanghai 9
Vienna 9
Abidjan 8
Bishkek 8
Brooklyn 8
Frankfurt am Main 8
Lappeenranta 8
London 8
Managua 8
Medford 8
Nassau 8
Nouakchott 8
Princeton 8
Warsaw 8
Accra 7
Amsterdam 7
Belo Horizonte 7
Dakar 7
Dallas 7
Guangzhou 7
Pordenone 7
Tbilisi 7
The Dalles 7
Amman 6
Baghdad 6
Belgrade 6
Istanbul 6
Jakarta 6
Johannesburg 6
Lahore 6
Mexico City 6
Montevideo 6
Panama City 6
Poplar 6
Pristina 6
Addis Ababa 5
Ankara 5
Boston 5
Brixen 5
Bến Tre 5
Denver 5
Dushanbe 5
Harare 5
Hargeisa 5
Jeddah 5
Totale 2.853
Nome #
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 488
Core needle biopsy of soft tissue tumors, CEUS vs US guided: a pilot study 362
Adoptive cell therapy of triple negative breast cancer with redirected cytokine-induced killer cells 300
Hyaluronan is a natural and effective immunological adjuvant for protein-based vaccines 293
Mitochondrial fission links ECM mechanotransduction to metabolic redox homeostasis and metastatic chemotherapy resistance. 272
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases 259
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1 252
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial 251
A paclitaxel-hyaluronan conjugate (ONCOFID-P-B™) in patients with BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the tumor microenvironment 245
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies 242
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling 221
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine 216
Transglutaminase Type 2-MITF axis regulates phenotype switching in skin cutaneous melanoma 181
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab 169
The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors 167
Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer 164
Extensive-stage small-cell lung cancer in patients receiving atezolizumab plus carboplatin-etoposide: stratification of outcome based on a composite score that combines gene expression profiling and immune characterization of microenvironment 164
Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma 156
A preclinical mouse model of hepatic metastasis to instruct effective treatment modalities 145
Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer 144
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells 140
Case report: Complete pathologic response with first-line immunotherapy combination in a young adult with massive liver dissemination of mismatch repair-deficient metastatic colorectal cancer: Immunological and molecular profiling 100
Radiation hardness properties and DCR reduction via laser annealing of InGaAs/InP SPADs for space applications 64
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications 49
Evolving frontiers in bladder cancer immunotherapy: integrating BCG, immune checkpoints, viral vectors, nanotechnology, and CAR-based therapies 39
Microbiome modulation uncouples efficacy and toxicity induced by immune checkpoint blockade in mouse multiple myeloma 32
Totale 5.115
Categoria #
all - tutte 13.407
article - articoli 12.093
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 257
Totale 25.757


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 0 3 99
2021/2022195 33 19 7 4 0 3 25 23 11 10 26 34
2022/2023223 22 18 20 42 27 26 18 7 22 4 15 2
2023/2024182 7 10 17 6 15 18 23 18 16 10 24 18
2024/2025903 30 81 85 25 68 38 48 77 76 35 142 198
2025/20263.222 210 206 326 449 265 182 476 300 382 209 217 0
Totale 5.115